NEW YORK, March 13, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Cree, Inc. (NASDAQ: CREE), Veeco Instruments Inc. (NASDAQ: VECO), Synopsys Inc. (NASDAQ: SNPS), Tessera Technologies Inc. (NASDAQ: TSRA), and ATMI Inc. (NASDAQ: ATMI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

--

Cree, Inc. Analyst Notes

On March 5, 2014, Cree, Inc. (Cree) announced the launch of the new CPW5 Z-Rec(R) high-power silicon-carbide (SiC) Schottky diodes. It is the industry's first commercially available family of 50-amp SiC rectifiers. It is designed to reduce costs, improve efficiency, simplify systems and increase reliability of SiC technology to high-power systems from 50 kW to over 1 MW. "As the sole distributor of Cree SiC-based power products in wafer and die form, SemiDice is excited to offer the CPW5 family of Z-Rec Schottky diodes," said Dan Cormack, CEO of SemiDice, Inc. "We are seeing increased customer demand for 50-amp Schottky diodes, and we know that as a global leader in the manufacture of advanced SiC diodes, Cree will deliver the quality and performance that our customers expect to help them minimize system cost and size." The CPW5 family of Z-Rec Schottky diodes includes 1700-V/50-A, 1200-V/50-A, 650-V/50-A and 650-V/30-A combinations. The full analyst notes on Cree, Inc. are available to download free of charge at:

http://www.AnalystsReview.com/03132014/CREE/report.pdf

--

Veeco Instruments Inc. Analyst Notes

On March 10, 2014, Veeco Instruments Inc. (Veeco) announced that IPG Photonics Corporation (IPG), made a purchase of an additional GEN2000(R) Production Molecular Beam Epitaxy (MBE) System to add to their fleet of Veeco MBE systems. IPG will use the GEN2000 for high-volume manufacturing of laser diodes for fiber lasers. "Veeco's GEN2000 is the perfect complement to our existing set of Veeco MBE systems because of its superior throughput and low production costs," said Dr. Alex Ovtchinnikov, Senior Vice President, Components at IPG Photonics. "Having the ability to transfer production methods from our other Veeco MBE systems means we can ramp laser diode production quickly and reliably to meet increasing demand for our fiber lasers." IPG Photonics Corporation is the world leader in high-power fiber lasers and amplifiers and now utilizes multiple Veeco MBE systems in its laser production operations. The full analyst notes on Veeco Instruments Inc. are available to download free of charge at:

http://www.AnalystsReview.com/03132014/VECO/report.pdf

--

Synopsys Inc. Analyst Notes

On February 19, 2014, Synopsys Inc. (Synopsys) and Coverity has signed a definitive agreement for Synopsys to acquire Coverity, the leading provider of software quality, testing, and security tools. Under the terms of the definitive agreement, Synopsys will pay approximately $375 million, or $350 million net of cash acquired. In addition, Synopsys will assume certain unvested stock options of Coverity employees. The transaction will be funded by Synopsys with a combination of US cash and debt, and is subject to Hart Scott Rodino regulatory review and other customary closing conditions. The acquisition is expected to close in Q2 FY 2014. Synopsys expects Coverity to contribute approximately $20 million to $25 million to FY 2014 revenue. The full analyst notes on Synopsys Inc. are available to download free of charge at:

http://www.AnalystsReview.com/03132014/SNPS/report.pdf

--

Tessera Technologies Inc. Analyst Notes

On February 27, 2014, Tessera Technologies Inc. (Tessera) announced that its subsidiary, Tessera, Inc., has entered into a settlement agreement with Powertech Technology, Inc., Powertech Technology (Suzhou) Co. Ltd., and Macrotech Technology, Inc. (collectively PTI) in relation to their pending cases in United States District Court for the Northern District of California. Under the terms of the settlement, PTI agrees to pay $196 million to Tessera, Inc. Further, if Tessera, receives a majority of the total amount owed by PTI under the settlement, and other conditions are met, by March 31, 2015, Tessera, Inc. and PTI will dismiss the pending cases. The full analyst notes on Tessera Technologies Inc. are available to download free of charge at:

http://www.AnalystsReview.com/03132014/TSRA/report.pdf

--

ATMI Inc. Analyst Notes

On February 20, 2014, ATMI, Inc. (ATMI) announced that it has completed the sale of ATMI LifeSciences to Pall Corp. The transaction includes all assets associated with the LifeSciences business. Cash proceeds from the transaction are approximately $185 million, subject to customary post-closing working capital adjustments. ATMI will report an after-tax gain during Q1 2014 related to this transaction of approximately $68 million. The full analyst notes on ATMI Inc. are available to download free of charge at:

http://www.AnalystsReview.com/03132014/ATMI/report.pdf

--

About Analysts Review We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

--

=============

EDITOR NOTES: 


        
        - This is not company news. We are an independent source and our views do
          not reflect the companies mentioned.
        - Information in this release is fact checked and produced on a best efforts
          basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human
          and are prone to make mistakes. If you notice any errors or omissions, please notify
          us below.
        - This information is submitted as a net-positive to companies mentioned, to
          increase awareness for mentioned companies to our subscriber base and the investing
          public.
        - If you wish to have your company covered in more detail by our team, or wish
          to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
        - For any urgent concerns or inquiries, please contact us at compliance [at]
          AnalystsReview.com.
        - Are you a public company? Would you like to see similar coverage on your
          company? Send us a full investors' package to research [at] AnalystsReview.com for
          consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

AnalystsReview.com

SOURCE Analysts Review